- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 924-938 of
1,371 results
1090 Exhibit: Auchus 2001
Document
IPR2016-01582, No. 1090-245 Exhibit - Auchus 2001 (P.T.A.B. Apr. 19, 2017)
|
|
Cite Document
2156 Exhibit: JSN 2156 Sartor, ¿¿¿The Continuing Challenge of Hormone Refractory...
Document
IPR2016-01582, No. 2156-225 Exhibit - JSN 2156 Sartor, ¿¿¿The Continuing Challenge of Hormone Refractory Prostate (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
1031 Exhibit: File History of USPN 8,822,438
Document
IPR2016-01582, No. 1031-30 Exhibit - File History of USPN 8,822,438 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
1043 Exhibit: Fisher 1993
Document
IPR2016-01582, No. 1043-42 Exhibit - Fisher 1993 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
1121 Exhibit: Deposition Transcript of Richard J Auchus, MD, PhD, Monday, April 1...
Document
IPR2016-01582, No. 1121-275 Exhibit - Deposition Transcript of Richard J Auchus, MD, PhD, Monday, April 10, 2017 Redacted (P.T.A.B. Apr. 19, 2017)
|
|
Cite Document
2060 Exhibit: JSN 2060 Marini et al, ¿¿¿The effect of adjuvant prednisone combined ...
Document
IPR2016-01582, No. 2060-139 Exhibit - JSN 2060 Marini et al, ¿¿¿The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients w...
|
|
Cite Document
2133 Exhibit: JSN 2133 Ryan, et al, ¿¿¿Phase I Clinical Trial of the CYP17 Inhibitor A...
Document
IPR2016-01582, No. 2133-203 Exhibit - JSN 2133 Ryan, et al, ¿¿¿Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity in Patients With Castration Resist...
|
|
Cite Document
2020 Exhibit: JSN 2020 Deposition Transcript of Scott Serels, MD, taken by Patent ...
Document
IPR2016-01582, No. 2020-101 Exhibit - JSN 2020 Deposition Transcript of Scott Serels, MD, taken by Patent Owner on August 22, 2016 in Amerigen Pharmaceuticals Ltd v Janssen Oncology, In...
|
|
Cite Document
2021 Exhibit: JSN 2021 Boumpas et al, ¿¿¿Glucocorticoid Therapy for Immune medi...
Document
IPR2016-01582, No. 2021-102 Exhibit - JSN 2021 Boumpas et al, ¿¿¿Glucocorticoid Therapy for Immune mediated Diseases Basic and Clinical Correlates,¿¿¿ Ann Internal Medicine, 1191198 1208...
|
|
Cite Document
1124 Exhibit: Second Supplemental Declaration of Robert D Stoner, PhD
Document
IPR2016-01582, No. 1124-287 Exhibit - Second Supplemental Declaration of Robert D Stoner, PhD (P.T.A.B. May. 12, 2017)
|
|
Cite Document
1128 Exhibit: Replacement of WCK1128
Document
IPR2016-01582, No. 1128-291 Exhibit - Replacement of WCK1128 (P.T.A.B. May. 12, 2017)
|
|
Cite Document
1125 Exhibit: Declaration of Lestin L Kenton Jr
Document
IPR2016-01582, No. 1125-288 Exhibit - Declaration of Lestin L Kenton Jr (P.T.A.B. May. 12, 2017)
|
|
Cite Document
1131 Exhibit: Supplemental to WCK1070
Document
IPR2016-01582, No. 1131-294 Exhibit - Supplemental to WCK1070 (P.T.A.B. May. 12, 2017)
|
|
Cite Document
2096 Exhibit: JSN 2096 Zytiga Usage ¿¿¿ total promotional spend
Document
IPR2016-01582, No. 2096-174 Exhibit - JSN 2096 Zytiga Usage ¿¿¿ total promotional spend (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2158 Exhibit: JSN 2158 ECOG Performance Status,¿¿¿
Document
IPR2016-01582, No. 2158-227 Exhibit - JSN 2158 ECOG Performance Status,¿¿¿ (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
